(PRWEB) November 28, 2014

The report provides qualitative insights on key market shares and drivers for all the important sub-segments of the market, in order to provide information about the projected growth rates. It maps the growth rates and market sizes for each sub-segment of the market and identifies the segments poised to witness rapid growth. It also includes analysis of the company profiles of the key market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report provides a competitive landscape of the Glycomics enzymes market. It covers the growth strategies adopted by the major industry players over the last three years and analyzes the industry developments like acquisitions and mergers, partnerships and agreements, and new product launches.

Get Full Report Here @ http://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html

Early buyers will receive 10% customization on this report.

Glycomics is increasingly being used in all fields of life science research, including drug discovery, diagnostics, immunology, and oncology. Glycomics is the study of glycan structures on bio-molecules. The growth of the market will be driven by increased funding for proteomics and Glycomics research, and increased research activities related to drug discovery.

The global Glycomics market was valued at $ 512.38 million in 2014. This market is expected to grow at a CAGR of 12.62% to reach $ 928.11 million in 2019. The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

Get PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=132685525

The application segments of drug discovery, development, and oncology will be important revenue pockets of the market in the forecast period (2014–2019). An increase in R&D expenditure by pharmaceutical and biotech companies and government support for the biotechnology industry will be the two most important growth drivers for this market in the forecast period (2012–2019). For instance, the Chinese government increased its basic research investment by 26% from 2011 to 2012 and decided to put more than $ 300 billion into biotechnology between 2012 and 2017. Investments of this nature will aid the growth of the market.

For Further Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=132685525

The global Glycomics market is highly evolved, with multiple different product segments. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by most players in this market, except New England Biolabs (U.S.) and Takara Bio, Inc. (Japan).

Glycomics is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes such as cell recognition, immune response, cell-to-cell interaction, infection and inflammation. These processes are dependent on the intricate glycan structures present on interacting biomolecules. Advanced technologies such as high-throughput mass spectroscopy, glycan microarrays, and carbohydrate chemistry are helping to unravel the complexity resulting from this diversity.

The other important growth strategy adopted by players in this market was expansion. This strategy was implemented to gain immediate technological competency and widen geographic presence. This strategy was adopted by all the players in this market, except Prozyme, Inc. (U.S.), and Waters Corporation (U.S.). Unlike their peers, these companies did not enter into any expansions between 2011 and 2014.

North America accounted for the largest share of the global market in 2014 and is expected to grow at the highest CAGR in the forecast period for this report (2012–2019). North America is expected to witness a steady year-on-year growth, owing to the trend of outsourcing drug discovery research activities to countries in this geography. Moreover, an increase in healthcare budgets and R&D activities in this region will further fuel the demand for products offered in the glycomics market.

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.).

Browse Related Reports:

Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), Research Area (Developmental Biology, Oncology) & by End User – Global Forecast to 2019

http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) – Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 full-time analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical info-graphics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan

North – Dominion Plaza,

17304, Preston Road,

Suite 800, Dallas, TX 75252

Tel: +1-888-600-6441

e-mail: sales(at)marketsandmarkets(dot)com

Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology






Tags